SS
VBIO

SBI Securities’s Valion Bio VBIO Stock Holding History

SBI Securities’s Portfolio VBIO Stock Details VBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8 Hold
1
– – ﹤0.01% 3942
2026
Q1 		$14 Hold
1
– – ﹤0.01% 3815
2025
Q4 		$23 Hold
1
– – ﹤0.01% 3756
2025
Q3 		$46 Hold
1
– – ﹤0.01% 3745
2025
Q2 		$66 Hold
1
– – ﹤0.01% 3657
2025
Q1 		$41 Hold
1
– – ﹤0.01% 3699
2024
Q4 		$106 Buy
+1
New +$116 ﹤0.01% 3437

Other funds holding VBIO

M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

SBI Securities's VBIO Position: Q2 2026 in Review

SBI Securities held its Valion Bio (VBIO) position steady in Q2 2026 at 1 share worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #3942.

SBI Securities first reported a position in VBIO in Q4 2024 and has held it in 7 quarters since. The position peaked at $106 in Q4 2024. 11 funds tracked by Wall St. Rank hold VBIO as of Q2 2026.

  • SBI Securities held 1 share of Valion Bio worth $8 as of Q2 2026.
  • SBI Securities left its Valion Bio share count unchanged in Q2 2026.
  • Valion Bio made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3942 holding.
  • SBI Securities first reported a position in Valion Bio in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Valion Bio position peaked at $106 in Q4 2024.
  • 11 funds tracked by Wall St. Rank held Valion Bio as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.